CClinicalTrials.gg
CompletedNCT03409393COPUSUpdated Sep 14, 2018

Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis

An interventional study of The COPUS intervention and Usual Care (OPUS treatment) in Schizophrenia, Schizotypal Disorder and First Episode Psychosis, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2018-09-14.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The aim of the COPUS study is to investigate, whether it is possible to recruit and retain young people with first-episode psychosis, to an 8 week supervised High-Intensity Functional Training intervention (HIFT) (i.e. COPUS Intervention) and to investigate if oxygen uptake, body composition and physical function improves following participation in the intervention.

Read the detailed description

The introduction of specialized early intervention (SEI) is stated to be the most successful recent addition to the treatment of schizophrenia and other psychotic illnesses. In Denmark, SEI teams called OPUS, offer early intervention treatment (i.e. OPUS treatment) to young patients between 18 and 35 years with first-episode psychosis. The OPUS treatment consists of three main pillars: modified assertive treatment, family involvement, and social skill training. OPUS treatment is delivered via multidisciplinary teams including psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists.

Despite considerable progress in treatment of schizophrenia, people diagnosed with schizophrenia live significantly shorter lives, compared to the rest of the population. The higher mortality rate can be partly explained by an increased risk of cardiovascular disease, including metabolic syndrome, which may be documented already in the first months after start of medical anti-psychotic treatment. It is widely acknowledged that physical activity constitutes a cornerstone in the prevention of cardiovascular disease and metabolic syndrome. Therefore, despite the influence of non-modifiable factors (e.g. genetics), it is reasonable to assume that physical activity can promote health and prevent somatic disease in people diagnosed with schizophrenia.

However, currently, physical activity is not included in early intervention treatment of schizophrenia. Moreover, people with schizophrenia may experience anxiety, loss of motivation, apathy and social isolation, which can constitute significant barriers for adherence to physical activity. Existing knowledge in relation to physical activity behaviour change and adoption is therefore difficult to transfer directly to people with schizophrenia. Development and testing of new initiatives, which can be integrated into clinical practice, and offered complementary to SEI are thus warranted.

Against this background, the aim of the current study (called the COPUS study) is to investigate, whether it is possible to recruit and retain young people with first-episode psychosis, to an 8-weeks supervised High-Intensity Functional Training (HIFT) intervention (i.e. COPUS intervention) and to investigate if oxygen uptake, body composition and physical function changes following participation in the COPUS intervention. The study is organized as a randomized mixed methods feasibility study.

The COPUS intervention is offered in a private fitness centre in the local community. The intervention contains three training sessions of one hour duration per week, with the recommendation to the participants, to take part in at least two sessions per week.

The investigators aim to include 30 participants whom will be randomly assigned (1:1) to either an intervention group receiving the COPUS intervention plus usual care (i.e. standard OPUS treatment) or a control group including only receiving usual care (i.e. standard OPUS treatment). Participants allocated to the control group are offered the COPUS intervention after eight weeks.

The design and choice of methods reflect the complexity of the intervention (combination of social and physical elements that are difficult to control and isolate) and the desire to establish a scientifically informed basis for a subsequent, up-scaled, pragmatic randomized multicentre study.

02

Conditions studied

  • Schizophrenia
  • Schizotypal Disorder
  • First Episode Psychosis
  • Psychotic Disorders
  • Schizoaffective Disorder

Keywords

  • Human
  • Denmark
  • Adult
  • Adolescent
  • Young Adult
  • Male
  • Female
  • Physical Activity
  • Maximum Oxygen Consumption
  • Resistance Training
  • High-Intensity Functional Training
  • Aerobic Exercise
  • Motivation
  • Feasibility
  • Relevance
  • Health Behavior
03

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 35 years
  • Diagnosed with Schizophrenia or Schizotypal disorders
  • Undergoing OPUS treatment for at least 6 months or stabilized medical anti-psychotic treatment
  • Danish speaking

Exclusion criteria

Exclusion Criteria:

  • Physical contraindications for physical activity
  • Pregnant (self-reported)
  • Unable to give adequately informed consent
  • Mentally disabled
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Intervention Group

    The COPUS intervention plus usual care (OPUS treatment).

    Other: The COPUS intervention · Other: Usual Care (OPUS treatment)

  • Other
    Control Group

    Usual care (OPUS treatment).

    Other: Usual Care (OPUS treatment)

Interventions

  • OtherThe COPUS intervention

    The COPUS intervention consists of 8 weeks of High-Intensity Functional Training (HIFT). The frequency of the training is 3 sessions per week and the duration is one hour per session. The intervention is group-based and supervised. Each training session includes warm-up (15 min), followed by 30 minutes of HIFT based on a range of varied functional exercises, including elements of strength training and aerobic exercise. The sessions are supervised by a trained physiotherapist and exercise physiologist supported by 2 two trained bachelor students in Sports Science.

  • OtherUsual Care (OPUS treatment)

    Usual care include specialised early intervention treatment (OPUS treatment) and consists of three main pillars: modified assertive treatment, family involvement, and social skill training. OPUS treatment is delivered via multidisciplinary teams include psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists. All team members, except for the psychiatrist, function as case managers. The ratio of patients to case managers must not exceed 12:1.

05

What researchers measure

Primary outcomes

  1. Assessment of changes in Physical Fitness (VO2max)

    Assessed by the maximum amount of oxygen the body can utilize during a specified period of intense exercise.

    Time frame: Change from Baseline Physical Fitness (VO2max) at 2 months.

  2. Recruitment Rate

    Registration of patients enrolled in the study compared to the total number of eligible patients.

    Time frame: Registration of recruitment occurs in the 4 weeks prior to the baseline tests.

  3. Retention Rate

    Registration of the participants attendance in the High-Intensity Functional Training compared with the number of possible training sessions during the period.

    Time frame: From baseline up to 4 months.

Secondary outcomes

  1. Assessment of changes in body weight

    The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining body weight.

    Time frame: Change from Baseline Body Weight at 2 months.

  2. Assessment of changes in fat percentage

    The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining fat percentage.

    Time frame: Change from Baseline Fat Percentage at 2 months.

  3. Assessment of changes in bone mass

    The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining bone mass.

    Time frame: Change from Baseline Bone Mass at 2 months.

  4. Assessment of changes in muscle mass

    The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining muscle mass.

    Time frame: Change from Baseline Muscle Mass at 2 months.

  5. Assessment of changes in Visceral Fat

    The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining visceral fat.

    Time frame: Change from Baseline Visceral Fat at 2 months.

  6. Assessment of changes in Resting Blood Pressure

    The participants' Resting Blood Pressure are tested according to the American Heart Association practice guidelines for blood pressure Measurement.

    Time frame: Change form Baseline Resting Blood Pressure at 2 months.

  7. Assessment of changes in countermovement jump height

    Determination of potential changes in countermovement jump height measured using the non-invasive Optojump system (www.optojump.com)

    Time frame: Change form Baseline Jump Height at 2 months.

  8. Assessment of changes in Leg Muscle Strength

    Determination of potential changes in leg muscle strength by the non-invasive 30-Second Chair Stand test. The test measures how many times the participant can reach a full standing position from a sitting position in 30 seconds. Score range from 0 and up with a higher score being considered as a better outcome.

    Time frame: Change form Baseline Leg Muscle Strength at 2 months.

  9. Assessment of changes in Hand Grip Strength

    Determination of potential changes in grip strength measured quantitatively using a hand dynamometer.

    Time frame: Change form Baseline Hand Grip Strength at 2 months.

  10. Assessment of changes in Balance

    Determination of potential changes in balance using the Flamingo Balance Test. The participant stands on a 3 centimeter wide beam while holding the instructors hand. The tests then measures how many times the participant loses balance in 60 seconds.Score range from 0 and up with a lower score being considered as a better outcome.

    Time frame: Change form Baseline balance at 2 months.

  11. Assessment of changes in Self-reported Physical Activity Behavior

    Assesment of changes in self-reported physical activity behaviour using the Physical Activity Scale (PAS). The PAS measures self-reported amount of time spent on different physical activities, such as sports, work, and leisure time during 24 hours on an average weekday. The activities are organized in nine different metabolic equivalent (MET) levels ranging from sleep/rest (0.9 METs) to high-intensity physical activities (\>6 METs). MET is the Metabolic Equivalent of Task and is a physiological measure expressing the energy cost of physical activities and is defined as the ratio of metabolic rate (and therefore the rate of energy consumption) during a specific physical activity to a reference metabolic rate. Therefore, higher MET scores in the Physical Activity Scale indicates a better outcome than lower scores.

    Time frame: Change from Baseline Physical Activity Behaviour at 2 months.

Other outcomes

  1. Monitoring of training intensity (for the Intervention Group only)

    Determination of whether the training intensity is adequate to increase Physical Fitness, the workload during training is continuously measured. A validated device called Actiheart which is both an accelerometer and a heart rate monitor is used to measure workload.

    Time frame: Through study completion, an average of 4 months

  2. Adverse events

    We will continuously record adverse events that may arise as a result of the intervention, including physical damage, discomfort and any deterioration of symptoms. The adverse events will be registred both in the intervention period and in the Control Group training period.

    Time frame: Through study completion, an average of 4 months

  3. Resource Consumption

    In order to evaluate the sustainability of the intervention, we want to register how much time (in minutes) OPUS staff spends on the project

    Time frame: Through study completion, an average of 4 months

06

Study locations

1 site
  • OPUS
    Brøndby, 2605, Denmark
07

References and documents

Publications

  • Midtgaard J, Schnor H, Bjerre ED, Jespersen T, Jelsoe N, Frolund N, Seier S, Ronbog JW, Nordsborg NB, Ebdrup BH. Exercise training complementary to specialised early intervention in patients with first-episode psychosis: a feasibility randomised trial. Pilot Feasibility Stud. 2021 Aug 19;7(1):162. doi: 10.1186/s40814-021-00900-5. PubMed 34412705 ↗
  • Larsen LQ, Schnor H, Tersbol BP, Ebdrup BH, Nordsborg NB, Midtgaard J. The impact of exercise training complementary to early intervention in patients with first-episode psychosis: a qualitative sub-study from a randomized controlled feasibility trial. BMC Psychiatry. 2019 Jun 21;19(1):192. doi: 10.1186/s12888-019-2179-3. PubMed 31226959 ↗
08

Registry details

Key details

Study ID
NCT03409393
Lead sponsor
Rigshospitalet, Denmark
Collaborators
University of Copenhagen, Mental Health Services in the Capital Region, Denmark
Responsible party
Julie Midtgaard (Associate Professor, Rigshospitalet, Denmark) — Principal investigator
First posted
Jan 24, 2018
Start date
Jan 22, 2018
Primary completion
Jun 20, 2018
Completion
Aug 1, 2018
Last update
Sep 14, 2018

Study contacts

Julie Midtgaard, Ph.D.
principal investigator · The University Hospitals Centre for Health Research (UCSF) / Copenhagen University Hospital (Rigshospitalet)
Helle Schnor, Ph.D.
study director · Mental health services in the Capital Region of Denmark, Psychiatric Center Glostrup

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion